Table 4. Projected Annual Additional National Costs and Cancers Detected With Use of Computed Tomography vs Ultrasound for Evaluation of Asymptomatic Microscopic Hematuria According to Rate of Compliance With Recommended Evaluation.
Compliance, % | Additional Costs, $ | Additional Cancers Detected | Cohort | Reference |
---|---|---|---|---|
100 | 389 914 648 | 60 | Theoretical | NA |
63 | 245 646 228 | 38 | Patients who underwent CT evaluation | Loo et al, 2013 |
49 | 191 058 177 | 30 | Patients who underwent any imaging | Buteau et al, 2014 |
36 | 140 369 273 | 22 | Patients who underwent upper and lower tract evaluation | Shinagare et al, 2014 |
5 | 19 495 732 | 3 | Patients who underwent upper and lower tract evaluation | Buteau et al, 2014 |
Abbreviations: CT, computed tomography; NA, not applicable.